Software
We build and operate our own computational drug discovery pipeline, from protein target to analysed simulation data, and develop new methods where existing options fall short.
Explore the platformSoftware · Research services · Training
Discovery Boulevard develops an in-house drug discovery pipeline, delivers CADD research services and consultancy, and trains researchers in the same validated workflows.

What we do
The pipeline we develop is the same one we use on client projects and teach in our workshops.
We build and operate our own computational drug discovery pipeline, from protein target to analysed simulation data, and develop new methods where existing options fall short.
Explore the platformCADD consultancy and project work for academic and industry groups: target assessment, ligand design, virtual screening, QSAR, molecular dynamics and custom pipeline deployment.
See our servicesLive hands-on workshops that teach researchers the same validated workflows we use in our own projects.
Browse trainingTraining
Clients and collaborators
We work with universities and medical schools as a contracted, officially onboarded vendor and as a research partner under signed collaboration agreements, with joint publications in preparation.
Wake Forest University School of Medicine
Winston-Salem, North Carolina, USA
Manipur University
Department of Biotechnology
Imphal, Manipur, India
National Institute of Technology Karnataka
Department of Metallurgical and Materials Engineering
Surathkal, Mangalore, Karnataka, India
Central University of Karnataka
Department of Life Science, School of Life Sciences
Kalaburagi, Karnataka, India
University of Hyderabad
Department of Biotechnology and Bioinformatics
Hyderabad, Telangana, India
Naresh Damuka, Angamba Meetei Potshangbam, Pritam Roy, Kiran K Solingapuram Sai
A joint study with the Department of Radiology at Wake Forest University School of Medicine, with Discovery Boulevard as a co-author. AI-driven generative design and virtual screening were combined to find brain-penetrant candidate PET tracers for the GLP-1 receptor, a target studied in Alzheimer's and Parkinson's diseases.
The poster was recognised at the October 2026 Colloquium of the Wake Forest Center for Artificial Intelligence Research, where lead author Naresh Damuka received the Early-Stage Investigator Award for outstanding contributions in AI research.
News

Our collaborative poster with Wake Forest University School of Medicine, on finding brain GLP-1 receptor PET tracers with AI-driven generative design and virtual screening, was recognised at the October 2026 CAIR Colloquium. Lead author Naresh Damuka received the Early-Stage Investigator Award for outstanding contributions in AI research.
See the collaboration
Dr. Angamba Meetei Potshangbam represented Discovery Boulevard and Algobiome LLP as invited speaker and session chair at BIOVISION 2047: BIORISE, the international conference organised by the School of Sciences, Noida International University (13–15 October 2026). The talk presented the AlgoVard Suite, our integrated computational drug discovery pipeline: DockFlow for structure-based virtual screening, LeadFlow for generative AI design and lead optimisation, and DynaFlow for molecular dynamics and binding free energy.
Explore our platform
Dr. Angamba Meetei Potshangbam, co-founder of Discovery Boulevard, was a resource person for the Two-Week Interdisciplinary Refresher Course in Biological Sciences, organised by the Malaviya Mission Teacher Training Centre (MMTTC), Manipur University, Canchipur. He spoke on Accelerating Drug Design with Artificial Intelligence: From Data to Discovery, and led a hands-on demonstration of basic bioinformatics tools for the participating faculty.
See our training programmes